Halal and Haram Considerations in Pharmaceuticals: Ethical and Scientific Perspectives

Abstract

The modern pharmaceutical industry has transformed healthcare through innovative drug formulations, biotechnology, and advanced manufacturing processes. However, these developments have simultaneously introduced complex ethical and religious concerns for Muslim patients regarding the permissibility of medicines. Pharmaceuticals often contain ingredients derived from animals, alcohol, microorganisms, or genetically modified sources, many of which raise serious questions under Islamic law (Sharī‘ah). This study critically examines the concepts of ḥalāl (lawful) and ḥarām (unlawful) in pharmaceuticals through an integrated framework combining Islamic jurisprudence (fiqh) and pharmaceutical sciences. Drawing upon primary Islamic sources including the Qur’ān and Hadith, classical juristic interpretations, and contemporary fatwas, this research analyzes controversial pharmaceutical ingredients such as gelatin, glycerin, enzymes, alcohol-based solvents, vaccines, hormones, and biotechnology-derived medicines. The study employs a qualitative doctrinal methodology and applies key Islamic legal maxims such as istiḥālah (chemical transformation), ḍarūrah (necessity), maṣlaḥah (public interest), and raf‘ al-ḥaraj (removal of hardship). The findings demonstrate that while certain pharmaceutical substances remain intrinsically prohibited, Islamic law provides conditional permissibility to protect human life and public health. The study concludes by emphasizing the urgent need for standardized halal pharmaceutical certification, interdisciplinary collaboration, and increased awareness among pharmacists and healthcare professionals to ensure ethical, safe, and Sharī‘ah -compliant medical care